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Abstract
Background: The efficacy of preventive zinc supplementation against diarrhea and respiratory illness may depend on
simultaneous supplementation with other micronutrients. We aimed to assess the effect of supplementation with zinc and
multiple micronutrients on diarrhea and other causes of non-malarial morbidity.
Methods and Findings: Rural Tanzanian children (n = 612) aged 6–60 months and with height-for-age z-score , –1.5 SD
were randomized to daily supplementation with zinc (10 mg) alone, multi-nutrients without zinc, multi-nutrients with zinc,
or placebo. Children were followed for an average of 45 weeks. During follow-up, we recorded morbidity episodes. We
found no evidence that concurrent supplementation with multi-nutrients influenced the magnitude of the effect of zinc on
rates of diarrhea, respiratory illness, fever without localizing signs, or other illness (guardian-reported illness with symptoms
involving skin, ears, eyes and abscesses, but excluding trauma or burns). Zinc supplementation reduced the hazard rate of
diarrhea by 24% (4%–40%). By contrast, multi-nutrients seemed to increase this rate (HR; 95% CI: 1.19; 0.94–1.50),
particularly in children with asymptomatic Giardia infection at baseline (2.03; 1.24–3.32). Zinc also protected against
episodes of fever without localizing signs (0.75; 0.57–0.96), but we found no evidence that it reduced the overall number of
clinic visits.
Conclusions: We found no evidence that the efficacy of zinc supplements in reducing diarrhea rates is enhanced by
concurrent supplementation with other micronutrients. By reducing rates of fever without localizing signs, supplementation
with zinc may reduce inappropriate drug use with anti-malarial medications and antibiotics.
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Introduction
There are no policy recommendations for preventive zinc
interventions in developing countries, despite evidence from a
recent meta-analysis of trials, mostly conducted in Asia and Latin
America, that it can reduce the overall rates of diarrhea and
respiratory illnesses by 20% and 14%, and rates of mortality by
6%. Results have varied between trials, however, probably due to
heterogeneity in study populations with respect to factors that
determine the response to zinc [1].
Zinc is required for DNA synthesis, RNA transcription, cell
division, cell activation and other basic biological functions at the
cellular level [2], and possibly for the functioning of tight junctions.
Zinc plays a critical role in maintaining epithelial barrier function
[3]. Its deficiency has been reported to reduce epithelial barrier
function [3], and to impair the development and functioning of
cells that mediate both innate and acquired immunity. In addition,
zinc possibly also has anti-inflammatory properties [2].
Zinc deficiency often coexists with other nutritional deficiencies,
and simultaneous supplementation of multiple micronutrients may
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be required to overcome the lack of response that can be found
when zinc is given alone [4]. In a recent review of steps to be taken
to translate research into zinc intervention programs, the
International Zinc Nutrition Consultative Group urged the
implementation of studies to assess the efficacy of zinc in
combination with other micronutrients [5].
Few trials have been conducted in Africa, where the etiology of
disease and environmental factors such as diet and micronutrient
deficiencies may be different from Asia and Latin America.
In this study, we aimed to assess the effect of supplementation
with zinc and multiple micronutrients on diarrhea and other
causes of non-malarial morbidity in young, rural Tanzanian
children. In addition, we explored baseline factors that determined
the magnitude of the morbidity response to such supplementation.
These baseline factors included infection with Giardia intestinalis,
because its role as diarrhea-causing agent is controversial: some
studies reported an association with acute and persistent diarrhea,
whereas others found no association, or even that Giardia infection
was associated with protection against acute diarrhea [6].
Methods
The protocol for this trial and supporting CONSORT checklist
are available as supporting information; see Checklist S1 and
Protocol S1. There were no important changes to methods after
trial commencement.
Ethics Statement
The study was approved by ethical review committees in The
Netherlands and Tanzania (National Health Research Ethics
Review sub-Committee). It was conducted in accordance with
guidelines expressed in the Declaration of Helsinki. We sought and
obtained written individual informed consent for all children;
parents or guardians were invited to sign (or thumbprint if
illiterate) the informed consent form in the presence of a member
of the community as impartial witness (who countersigned the
form).
Study Area
The study was part of a trial (ClinicalTrials.gov:
NCT00623857) with the primary aim to assess the effects of
supplementation with zinc and other micronutrients on malaria
rates. Details of study design and effects on malaria rates are
reported elsewhere [3]. The trial was performed in four villages
(Ngojoro, Kwangwe, Bondo and Kwadoya) near Segera (S
05u23.050, E 038u34.745) in Handeni District, north-eastern
Tanzania. This rural area is highly endemic for malaria, and
access to health care is limited, with no primary care facilities in
the study area except the research dispensary that was constructed
specifically for this study. The vast majority of families live in self-
constructed clay houses, few with adjacent pit-latrines. Most
households are self-sustaining and the dietary intake of the
children restricted to maize and beans, with very low intake from
animal products. This food contains a high concentration of
phytates that limits the absorption of several trace elements,
including zinc.
Recruitment
Data were collected between February 2008 and March 2009.
All resident children aged 6–60 months were invited for screening.
Venous blood and fresh stool samples were collected, anthropo-
metric measurements recorded in duplicate, and children were
examined by a clinical officer. Children were eligible when having
a height-for-age z-score # –1.5 SD (which tends to select for zinc
deficiency) [7], weight-for-height z-score . –3 SD (thus excluding
severely wasted children for ethical reasons), no signs of severe
chronic diseases, and hemoglobin concentration .70 g/L. Chil-
dren whose parents refused consent or intended to move outside
the study area during the follow-up period were excluded.
Randomization and Interventions
Children were randomized within 6 strata defined by malaria
infection (binary) and age class (6–17 months, 18–35 months and
36–60 months) and randomly permuted blocks with size randomly
selected of 4 or 8. A colleague not otherwise involved in the trial
used tables with random numbers to generate the allocation
sequence. Children received daily supplements with either zinc
alone (10 mg as gluconate), multi-nutrients without zinc, zinc
combined with multi-nutrients or placebo. The levels of magne-
sium and vitamin C in the multi-nutrient supplement were below
upper limits that were based on osmotic diarrhea and related
gastrointestinal disturbances as critical endpoints [8]; further
details about the composition of the multi-nutrient supplement are
shown in Table 1. Supplements were packed as transparent blister-
strips, each containing 15 capsules with powder that was similar in
taste and appearance for all 4 intervention groups. Capsules were
color-coded to reduce the chance that children would receive the
wrong supplement. The color code was not disclosed to the
researchers until after the database had been finalized.
Follow-up and Case Detection
Supplementation was performed by community volunteers,
each supervising approximately 20 children. Supplements were
taken out of capsules, mixed with water and administered early in
the morning. All volunteers reported daily to the research
dispensary, and project staff followed up immediately in case a
child had missed a daily supplementation dose. Parents or
guardians were requested to bring study children to the dispensary
when they noticed fever or when their child was otherwise unwell.
A clinical officer was on permanent duty, and assessed sick
children according to a standardized form. In case of reported
cough or difficult breathing, the clinical officer looked for signs of
respiratory distress and counted breathing frequency twice, each
time for one full minute. All children received first-line treatment
free of charge. When indicated, they were referred and provided
with transport to the nearest district hospital. Parents could
withdraw consent at any time.
Supplementation and follow-up continued until 12 March 2009,
when the trial was stopped for all children simultaneously. We
started the study at a later date than originally foreseen, and had to
stop the trial when running out of resources, before the planned
number of person-years were accrued, but after the desired
number of events had been accrued.
Outcome Definitions
We used the following pre-defined case definitions: 1) Diarrhea:
guardian-reported loose or watery stools, with episodes separated
by at least 48 h. To increase the specificity of the case definition
we also defined cases as episodes as defined above with .3 loose
or watery stools during a 24-h period; 2) Acute lower respiratory
infections (ALRI): reported cough with respiratory rate exceeding
age-specific cut-off values (.50/min or .40/min for children
aged 6–12 months and 12–60 months, respectively [9]); 3) Severe
pneumonia: ALRI as defined above with one or more danger signs
(lower chest in drawing, nasal flaring, grunting or head nodding)
[9]; 4) Any respiratory illness: guardian-reported cough or difficult
breathing; 5) Fever without localizing signs: guardian reported fever
that was not accompanied by cough, diarrhea or other localizing
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signs and with a negative result for a malaria dipstick test; 6) Any
other illness: guardian-reported illness with symptoms involving skin,
ears, eyes and abscesses, but excluding trauma or burns. Malaria
was defined by a positive result for the malaria dipstick test in
children with guardian-reported fever with either a) confirmed
fever (axillary temperature$37.5uC), or b) unconfirmed fever with
inflammation (whole blood C-reactive protein concentrations
$8 mg/L), separated by at least 14 days from a previous malaria
episode. The definitions provided above are not always mutually
exclusive. In those cases when illness episodes fulfilled the criteria
for more than one definition, they contributed to the analyses of all
of these case definitions. Children who attended the dispensary for
invited follow-up visits were only counted as new episode if
presenting with new symptoms.
Laboratory Procedures
Venous blood samples were collected in tubes with EDTA and
centrifuged within 2 h after collection. An aliquot was analyzed
the same day by hematology analyzer (Sysmex KX21, Kobe,
Japan). As a measure of inflammation, we measured whole blood
C-reactive protein concentration in the field by immunoturbidi-
metric assay (QuikRead, Orion Diagnostica, Espoo, Finland).
Plasma concentrations of zinc were determined by inductively-
coupled plasma-mass spectrometry. Plasma concentrations of C-
reactive protein and ferritin were measured in The Netherlands
on a Beckman Coulter Unicel DxC880i system. Stool samples
collected during the surveys were preserved in sodium acetate
acetic acid formalin, stored at 4uC and tested for Giardia
intestinalis parasites by enzyme-linked immunosorbent assay
(ProSpecT Giardia Microplate Assay, ProSpecT Giardia Micro-
plate Assay, Oxoid, Basingstoke, UK). This test has a sensitivity
and specificity of 93% and 100%, respectively, as compared to
detection by either microscopy or the EIA in at least one of two
sequential stool samples from individual subjects [10].
Statistical analysis. All data were double-entered, cleaned
and analyzed in SPSS (v15?0 for Windows, SPSS, Chicago, IL)
and STATA (v11; College Station, Tx). Compliance was
measured as the proportion of children who consumed 95% of
scheduled supplements. Height-for-age z-scores were calculated
based on the NCHS/WHO growth reference, using Epi Info
(version 3.3.2; http://www.cdc.gov/epiinfo). Being stunted was
defined as height-for-age z scores , –2 SD. New growth charts
have become available for children (WHO Anthro Software, 2007;
http://www.who.int/childgrowth/software/en/, [11]) since we
planned our study; use of these new charts would likely have led to
more children being classified as being stunted. Differences in
proportions were calculated using CIA [12].
We report incidence rates, and used Cox proportional hazard
models to assess intervention effects as crude and adjusted hazard
ratios, as assessed in an intention-to-treat analysis. We explored
effects on diarrhea and respiratory illness by analyzing cases with
and without fever separately. We conducted subgroup analyses to
explore potential effect-modification by age class (as defined by the
strata used for randomization), being stunted, and the presence of
G. intestinalis infection at baseline. In this analysis, we pooled
children aged 18–35 months and 16–60 months because there
Table 1. Target dose and form of multi-nutrient supplement (including zinc).
Active
substance Target level Form Infants 6–12 months Children 1–3 years Children 4–5 years
Declared Overage * Formulated RNI UL RNI UL RNI UL
Vitamin A 300 mg RAE 50% 450 mg RAE{ All-trans retinyl acetate (powder) 400 mg 600 mg 400 mg 600 mg 450 mg 900 mg
Vitamin B1 0.5 mg 25% 0.625 mg Thiamin mononitrate 0.3 mg ND 0.5 mg ND 0.6 mg ND
Vitamin B2 0.5 mg 10% 0.55 mg Riboflavin 0.4 mg ND 0.5 mg ND 0.6 mg ND
Niacin 6 mg NE 10% 6.6 mg Niacin 4 NE ND 6 NE 10 mg 8 NE 15 mg
Vitamin B6 0.5 mg 15% 0.575 mg Pyridoxine 0.3 mg ND 0.5 mg 30 mg 0.6 mg 40 mg
Folate 150 mg DFE 25% 93.75 mg{ Folic acid 80 mg ND 160 mg 300 mg DFE 200 mg 400 mg DFE
Vitamin B12 0.9 mg 30% 1.17 mg Cyanocobalamid in mannitol 0.5 mg ND 0.9 mg ND 1.2 mg ND
Vitamin C 50 mg 50% 75 mg Purified L-ascorbic acid 30 mg ND 30 mg 400 mg 30 mg 650 mg
Vitamin D 5 mg 35% 6.75 mg1 Vitamin D3 (cholecalciferol) 5 mg 25 mg 5 mg 50 mg 5 mg 50 mg
Vitamin E 6 mg TE 10% 6.6 mg RRR-a-tocopherol acetate 0.6 mg/kg bw|| ND 6 mg|| 200 mg 7 mg|| 300 mg
Vitamin K 30 mg 50% 45 mg Phylloquinone (vitamin K1) 5% 10 mg ND 15 mg ND 20 mg ND
Zinc 10 mg 0% 10 mg Zinc as gluconate 8.4 mg 5 mg 8.3 mg 7 mg 9.6 mg 12 mg
Iron 18 mg 0% 18 mg Ferrous fumarate 18.6 mg 40 mg 11.6 mg 40 mg 12.6 mg 40 mg
Iodine 90 mg 0% 90 mg Potassium iodate 90 mg ND 90 mg 200 mg 90 mg 300 mg
Copper 340 mg 0% 340 mg Cupric gluconate 220 mg 5 ND 340 mg 5 1 mg 440 mg 5 3 mg
Selenium 20 mg 0% 20 mg Sodium selenate 10 mg 60 mg 17 mg 90 mg 22 mg 150 mg
Magnesium 65 mg 0% 65 mg Trimagnesium dicitrate anhydrous 54 mg ND 60 mg 65 mg " 76 mg 110 mg "
RNI: Recommended Nutrient Intake as established by WHO/FAO [8]; UL: Tolerable Upper Intake Level as established by FNB/IOM [23]; RAE: retinol activity equivalents;
NE: niacin equivalents; DFE: dietary folate equivalents; TE: a-tocopherol equivalents; ND: Not derived.
*Overage is calculated from declared amount (D) and formulated amount (F) as O= (F-D)*100/D.
{Equivalent to 1,500 IU.
{Based on IOM estimates that 0.5 mg folic acid taken on an empty stomach corresponds to 1 mg DFE.
1Equivalent to 270 IU.
||Values obtained from [18).
"UL applies to supplementary Mg.
doi:10.1371/journal.pone.0041630.t001
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were only 44 cases in the oldest age class. We explored to what
extent adjustment for factors that were predictive for morbidity
(age class, stunting, distance to the dispensary [$ or,4 km, which
is close to the median], and mosquito net use) influenced estimates
of the intervention effects.
Results
The trial profile is shown in Figure 1. Baseline characteristics
were similar between intervention groups (Table 2). The
prevalence of zinc deficiency was high (67%). Giardia infection
was detected in 192 children (31%), and 426 children (70%) were
stunted.
Twenty children (3%) did not complete the trial: three died, two
were withdrawn by parents, and 15 emigrated from the area
(Figure 2). Another two children discontinued the intervention
but were available for follow-up. Compliance was high (96%) and
similar in all four groups.
There were 3,268 clinic visits during the study period, of which
2,462 (75%) were accompanied by guardian-reported fever and
1,572 (48%) classified as malaria. Among the non-malarial fever
cases, 658 were accompanied by diarrhea, cough, or other
localizing signs, either alone or in combination, while 232 fever
cases were without localizing signs (Table 3). For 223 children
(36%), parents or caretakers reported at least one episode of
diarrhea. A total of 390 diarrhea episodes were recorded, with an
incidence rate of 0.74/child-year. There were 1,333 episodes of
reported cough, but only few (181) fulfilled criteria of ALRI as
established by the World Health Organization [6]. The number of
severe pneumonia cases (24) was insufficient for meaningful
analysis. There were 744 visits for other reasons, mainly abscesses
and symptoms involving skin, ears, and eyes.
Figure 1. Trial profile. Compliance was measured as the proportion of children who consumed.95% of scheduled supplements.
doi:10.1371/journal.pone.0041630.g001
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Table 2. Baseline characteristics of study participants, by intervention group.
Zinc
Multi-nutrients
without zinc
Multi-nutrients with
zinc Placebo
N 153 155 151 153
Sex M/F [n/n] 70/83 [46%/54%] 87/68 [56%/44%] 66/85 [44%/56%] 76/77 [50%/50%]
Age 32.5 (15.4) 32.2 (15.7) 32.5 (15.5) 32.7 (16.1)
Plasmodium infection* 66 [43%] 64 [41%] 67 [44%] 68 [44%]
Height-for-age, z-score –2?36 (0?69) –2?50 (0?69) –2?39 (0?71) –2?45 (0?69)
Inflammation{ 52 [34%] 51 [33%] 51 [34%] 47 [31%]
Giardia intestinalis infection{ 50 [33%] 54 [35%] 42 [28%] 46 [30%]
Zinc deficiency1 97 [63%] 110 [71%] 105 [70%] 100 [65%]
Iron deficiency|| 23 [23%] 25 [24%] 24 [24%] 25 [24%]
Hemoglobin concentration, g/L 101?8 (12?6) 102?7 (12?8) 103?8 (12?7) 102.8 (12?7)
Distance from homestead to dispensary, km" 3?66 (2?31) 3?52 (2?06) 3?54 (2?07) 3?60 (3?38)
Mosquito net use ** 48 [32%] 55 [36%] 45 [30%] 46 [31%]
Mean (SD), % [n] unless indicated otherwise.
*As indicated by a positive result for pLDH-based dipstick test (see text).
{Plasma C-reactive protein concentration $8 mg/L.
{Stool samples could not be analyzed for 54 children (with 13, 14, 15 and 12 missing values in the 4 intervention groups). Prevalence calculated with total group
numbers in denominator.
1Plasma zinc concentration ,9.9 mmol/L.
||Plasma ferritin concentration ,12 mg/L (6 missing values); restricted to children without inflammation at baseline (n = 101, 104, 100 and 106, respectively).
"Measured as the crow flies, based on global positioning data.
**Data missing for 11 children.
doi:10.1371/journal.pone.0041630.t002
Figure 2. Effect of supplementation with zinc (left panel) or multi-nutrients (right panel) on selected morbidity outcomes. The effect
of zinc was assessed by hazard ratios in the pooled groups receiving zinc (with or without multi-nutrients) versus the pooled groups receiving no zinc
(with or without multi-nutrients); the effect of multi-nutrients was assessed by hazard ratios in the pooled groups receiving multi-nutrients versus the
pooled groups receiving placebo or zinc. Values between brackets (left) indicate the number of episodes for each illness definition. Horizontal line
bars indicate 95% CIs. Estimates are adjusted for age class (indicated by dummies) and distance between homestead and research dispensary (, or
$4 km); further adjustment for mosquito net use, sex, plasma zinc concentration, iron status or inflammation at baseline did not markedly change
the effect estimates.
doi:10.1371/journal.pone.0041630.g002
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Upon examination of interaction effects (Table 4), we found no
evidence that concurrent supplementation with multi-nutrients
influenced the magnitude of the effect of zinc on rates of diarrhea,
respiratory illness, fever without localizing signs, or other illness.
Thus in the remainder of this report, we will present marginal
effects whereby the effect of multi-nutrients is assessed by
comparing the pooled groups receiving placebo or zinc with the
pooled groups receiving multi-nutrients, and the effect of zinc is
assessed by comparing the pooled groups receiving no zinc (with
or without multi-nutrients) and the pooled groups receiving zinc
(with or without multi-nutrients).
Zinc supplementation reduced the rate of diarrhea by 24%
(95% CI: 4% to 40%) (Figure 2), while multi-nutrients seemed to
increase rates by 19% (–6% to 50%). We found similar effects
when restricting the analysis to cases of diarrhea with $3 loose
stools/24 h (Figure 2). The protective effect appeared more
evident for cases of diarrhea that were accompanied by fever (HR
0.73; 0.55–0.98) than for those not accompanied by fever (HR
0.80; 0.55–1.16), but the difference in effect was small.
There was no evident effect of either intervention on episodes of
respiratory illness, whether defined as reported cough or as cough
with fast breathing, or on episodes of other illnesses (Figure 2). By
contrast, zinc reduced the rates of fever without localizing signs by
25% (4%–43%; adjusted for age class and distance between
homestead and research clinic).
Age was strongly predictive for all morbidity outcomes, but
there was no evidence that age class influenced the magnitude of
the effect of the interventions for any of the outcomes considered
(not shown). We found weak evidence that the zinc-induced
reduction in diarrhea rates was more pronounced in stunted
Table 3. Incidence rates for various illnesses, stratified by the presence of fever.
All Fever reported No fever reported
Total observation time, child-years 526 526 526
All clinic visits 6.2 (3,268) 4.7 (2,462) 1.5 (806)
Diarrhea
Guardian-reported episodes 0.74 (390) 0.47 (248)* 0.27 (142)
.3 loose stools/24 h 0.44 (233) 0.41 (216) 0.03 (17)
Respiratory illness
Cough 2.5 (1,333) 1.9 (998)* 0.64 (334)
Cough with fast breathing 0.34 (181) 0.28 (147)* 0.06 (34)
Severe pneumonia 0.05 (24) 0.04 (20) 0.01 (4)
Other illnesses { 1.4 (744) 0.68 (3,566)* 0.74 (388)
Fever without localizing signs { 0.44 (232) NA NA
Malaria 3.0 (1,572) NA NA
Hospital referrals 0.13 (68) 0.13 (68) 0.00 (0)
Values indicate the total number of episodes per child-year observed. Numbers between brackets indicate the number of episodes.
NA: Not applicable (fever is part of the case definition).
*Among these, the following number of cases was also classified as malaria: reported diarrhea: 137 (35%); reported diarrhea with $3 loose stools/24 h: 69 (30%);
reported cough: 491 (36%); other: 166 (22%).
{Includes symptoms of skin, ears, and eyes and abscesses; excluding trauma or burns.
{Cases classified as fever without localizing signs are not included in any of the other categories.
doi:10.1371/journal.pone.0041630.t003
Table 4. Incidence of various illnesses, by treatment group.
Zinc
Multi-nutrients
without zinc
Multi-nutrients with
zinc Placebo Interaction effect* p
Child-years at risk 130.8 133.2 129.7 131.9
Diarrhea
All reported episodes 0.62 (81) 0.92 (123) 0.67 (87) 0.75 (99) 0.88 (0.52–1.51) 0.65
.3 loose stools/24 h 0.35 (46) 0.56 (74) 0.42 (55) 0.44 (58) 0.96 (0.51–1.80) 0.89
Respiratory illness
Cough 2.5 (322) 2.5 (333) 2.7 (354) 2.5 (324) 1.09 (0.80–1.48) 0.57
Cough with fast breathing 0.34 (45) 0.32 (43) 0.39 (50) 0.33 (43) 1.13 (0.57–2.24) 0.72
Other 1.5 (195) 1.4 (186) 1.3 (169) 1.5 (194) 0.92 (0.62–1.37) 0.68
Fever without localizing signs 0.39 (51) 0.45 (60) 0.37 (48) 0.55 (73) 1.17 (0.66–2.06) 0.60
Values indicate the total number of episodes per child-year observed. Numbers between brackets indicate the number of cases.
*Measured in a Cox proportional hazard model as the hazard ratio associated with the interaction term between zinc and multi-nutrients.
doi:10.1371/journal.pone.0041630.t004
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children (0.66; 0.49–0.90) than in those with a lesser degree of
stunting (0.95; 0.62–1.45; interaction effect: 0.68 (0.41–1.15);
Figure 3; upper panel, left).
The effect of multi-nutrient supplementation on diarrhea
depended on the presence of Giardia infection at baseline
(Figure 3; upper panel): multi-nutrient supplementation doubled
the rate of diarrhea among those with Giardia at baseline (2.03;
1.24–3.32), whereas it had no obvious effect among those without
Giardia infection (1.03; 0.78–1.36). This difference in intervention
effect between Giardia-positive and Giardia-negative children was
independent of age and stunting, and unlikely to have occurred by
chance (interaction effect: 1.98; 1.13–3.47; p = 0.02).
With regards to the effects of multi-nutrients on fever without
localizing signs, patterns observed in the subgroup analysis largely
resembled those observed for diarrhea (Figure 3; lower panel).
Both Giardia infection and being stunted at baseline determined
the magnitude of the effect of multi-nutrients on disease rates.
Multi-nutrients resulted in increased rates (1.39; 0.82–2.36) in
children with Giardia infection and decreased rates in those without
(0.74; 0.53–1.03) (interaction effect: 1.86; 1.00–3.47). In stunted
children, however, multi-nutrients decreased rates (0.67; 0.46–
0.97), whereas in children with a lesser degree of stunting, multi-
nutrients seemed to increase rates (1.46; 0.93–2.28; interaction
effect: 0.47; 0.26–0.83).
Lastly, multi-nutrients also increased the rate of reported cough
among stunted children, but not so in their less stunted
counterparts (HR: 1.34; 1.06–1.69 versus 0.98; 0.82–1.17; p-value
for interaction: 0.05). When analyzing effects on ALRI, a similar
pattern was seen (1.41; 0.79–2.52 versus 0.99; 0.65–1.50 among
stunted and less stunted children respectively), but the number of
Figure 3. Subgroup analysis of effects of supplementation with zinc or multi-nutrients on diarrhea (top panels) and fever without
localizing signs (bottom panels). Effects are indicated by hazard ratios (see Figure 2), with p-values for interaction tests. Values between brackets
(left) indicate the number of children in each subgroup. Horizontal line bars indicate 95% CIs. Effects are adjusted for age class, being stunted and
distance (, or $4 km) unless these factors were used to define subgroups. Because the presence of Giardia infection could not be assessed in 54
children due to missing stool samples, the analysis is based on fewer cases of diarrhea (361) and fever without localizing signs (216) than reported in
the text.
doi:10.1371/journal.pone.0041630.g003
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cases was lower and thus the statistical evidence for this interaction
weaker (p = 0.33).
Discussion
We found no evidence that the effect of zinc supplementation
on any of the morbidity outcomes assessed was influenced by
concurrent supplementation with other micronutrients. Daily
supplementation with zinc reduced the rate of fever without
localizing signs by approximately one-quarter. By contrast,
supplementation with multi-nutrients seemed to increase the rate
of diarrhea, mostly so in children with Giardia infection at baseline.
Many micronutrients, including zinc, are believed to play a role
in innate and adaptive immune responses, notably in the
proliferation and differentiation of Th1 and Th2 lymphocyte
subsets in response to infection [13]. Because the effector
mechanisms of these micronutrients may involve the same causal
pathway, we hypothesized that an inadequate intake and
deficiency would act synergistically in causing morbidity. Our
findings may indicate that this hypothesis is incorrect and that such
interaction truly does not exist, or the interaction effect may have
been too small to allow detection in our trial.
The effect of zinc on diarrhea found in our study is consistent
with the 20% reduction reported in a recent systematic review [1].
Contrary to the findings from this meta-analysis [1], however, we
found no evidence that this protection depended on age class. The
meta-analysis also showed that the preventive effect of zinc
supplementation against diarrhea decreased with baseline height
[1]. Our results suggested a similar influence by the initial degree
of stunting (Figure 3) but the statistical support for such interaction
was weak (p= 0.15). The incidence of diarrhea in our study was
comparatively low, however, and the number of cases may have
been too low to show such effect modification. For the same
reason, we may have failed to show an effect of either zinc or
multi-nutrients on rates of respiratory illnesses.
Based on findings from the same trial, we reported no evident
effect of zinc against malaria [3]. Because they are inoculated
through mosquito bites, malaria parasites bypass epithelial barriers
that form the first line of defense against pathogens that cause
diarrhoea and respiratory infections. The protective effect of zinc
against diarrhoea, as compared to the absence of such an effect
against malaria, suggests that, in our study population, zinc
primarily acted by strengthening barrier function rather than
through immunity.
Multi-nutrient supplementation seemed to increase diarrhea
rates by 25%. This adds to findings, based on data from the same
trial, that multi-nutrients increase the rate of first malaria attacks
by 30% (8%–55%; figure 2), and the rate of all malaria episodes
among the children aged 6–17 months and those with iron
deficiency by 26% (25% to 53%) and 41% (9%–82%),
respectively [3]. Subgroup analysis suggested that multi-nutrients
more than doubled diarrhea rates among children with Giardia
infection at baseline. This finding is discussed in detail elsewhere
[10].
Two other trials that investigated the added benefit of multi-
nutrients in addition to zinc in preventing episodes of diarrhea also
failed to show an advantage of combined supplementation above
supplementation with zinc alone. In Peruvian preschool children,
zinc alone tended to reduce the risk of diarrhea and respiratory
illness, whereas supplementation with multi-nutrients including
zinc tended to increase this risk [14]. In South African children,
there was no evidence that supplementation with multi-nutrients
including zinc was more efficacious than zinc alone in reducing the
burden of diarrhea or respiratory illnesses [15,16]. Taken together,
these findings do not support and even caution against multi-
nutrient supplementation in areas that are endemic for malaria
and other infectious diseases.
Giardia infection at baseline influenced the effect of multi-
nutrients on rates of fever without localizing signs in a similar
pattern as the effect on diarrhea, even when adjusting for age and
distance between homestead and research clinic. Although our
definition of fever cases without localizing signs excluded cases of
diarrhea, this similarity in effect patterns (including the fact that
zinc protected against both outcomes) suggests that many of these
fever episodes may have been due to enteric infections. Further
studies are needed to establish whether Giardia infection caused
this effect modification or whether it was a marker of an unknown
factor that may have played such a role, and to identify the
mechanisms involved.
Our study design did not allow us to identify single nutrients
that may have caused the increase in diarrhea associated with the
multi-nutrient supplement among children with Giardia. At the
doses provided, it is unlikely that magnesium or vitamin C caused
osmotic diarrhea; we also found no evidence, which otherwise
might have been expected, that the increased diarrhea rates were
larger in the youngest children who received a larger dose per
body weight that older children (Figure 3). Whilst most
micronutrients seem to protect against diarrhea [17], supplemen-
tation with iron may increase the diarrhea incidence [18], possibly
by enhancing proliferation and virulence of enteric pathogens, or
facilitating pathogen invasion by increasing permeability of the
small intestine [19,20]. Iron may also influence or impair the
immune responses to pathogens [17]. In vitro studies using Caco-2
cells suggest that copper may also impair intestinal barrier function
by enhancing paracellular permeability [21,22].
We found no evidence that the addition of vitamins and other
minerals to zinc supplements is helpful in preventing morbidity; in
fact, it may increase the diarrhea rates in specific subgroups. This
study adds support that zinc supplementation reduces the risk of
diarrhea in African children and, although it did not reduce the
overall number of clinic visits, it may reduce inappropriate use of
anti-malarial drugs and antibiotics by reducing rates of fever
without localizing signs. Our results should therefore encourage
efforts to increase the intake of zinc in vulnerable populations.
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